150 related articles for article (PubMed ID: 22702953)
1. Structural and biochemical consequences of disease-causing mutations in the ankyrin repeat domain of the human TRPV4 channel.
Inada H; Procko E; Sotomayor M; Gaudet R
Biochemistry; 2012 Aug; 51(31):6195-206. PubMed ID: 22702953
[TBL] [Abstract][Full Text] [Related]
2. Structural analyses of the ankyrin repeat domain of TRPV6 and related TRPV ion channels.
Phelps CB; Huang RJ; Lishko PV; Wang RR; Gaudet R
Biochemistry; 2008 Feb; 47(8):2476-84. PubMed ID: 18232717
[TBL] [Abstract][Full Text] [Related]
3. Structural Pharmacology of TRPV4 Antagonists.
Fan J; Guo C; Liao D; Ke H; Lei J; Xie W; Tang Y; Tominaga M; Huang Z; Lei X
Adv Sci (Weinh); 2024 Jul; 11(25):e2401583. PubMed ID: 38659239
[TBL] [Abstract][Full Text] [Related]
4. Wild-type and brachyolmia-causing mutant TRPV4 channels respond directly to stretch force.
Loukin S; Zhou X; Su Z; Saimi Y; Kung C
J Biol Chem; 2010 Aug; 285(35):27176-27181. PubMed ID: 20605796
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into the TRPV4-RhoA complex offer clues to solve the puzzle of TRPV4 channelopathies.
Hu X; Hu H
Cell Calcium; 2023 Dec; 116():102814. PubMed ID: 37839180
[No Abstract] [Full Text] [Related]
6. "When the Going Gets Tough": Novel Roles for TRPV4 in Stiffness-induced Phagolysosome Maturation.
Estrada-Bernal A; Sharma L; Shah FA
Am J Respir Cell Mol Biol; 2024 Jun; 70(6):431-432. PubMed ID: 38502902
[No Abstract] [Full Text] [Related]
7. Brain Penetrant LRRK2 Inhibitor.
Choi HG; Zhang J; Deng X; Hatcher JM; Patricelli MP; Zhao Z; Alessi DR; Gray NS
ACS Med Chem Lett; 2012 Aug; 3(8):658-662. PubMed ID: 23066449
[TBL] [Abstract][Full Text] [Related]
8. Photochemical restoration of visual responses in blind mice.
Polosukhina A; Litt J; Tochitsky I; Nemargut J; Sychev Y; De Kouchkovsky I; Huang T; Borges K; Trauner D; Van Gelder RN; Kramer RH
Neuron; 2012 Jul; 75(2):271-82. PubMed ID: 22841312
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-dependent intramembrane rhomboid protease promotes ERAD of membrane proteins.
Fleig L; Bergbold N; Sahasrabudhe P; Geiger B; Kaltak L; Lemberg MK
Mol Cell; 2012 Aug; 47(4):558-69. PubMed ID: 22795130
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin V2R-targeting peptide carrier mediates siRNA delivery into collecting duct cells.
Jung HJ; Lim JS; Choi HJ; Lee MS; Kim JH; Kim SY; Kim S; Kim E; Kwon TH
PLoS One; 2012; 7(6):e40010. PubMed ID: 22761946
[TBL] [Abstract][Full Text] [Related]
11. Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons.
Kuhn PH; Koroniak K; Hogl S; Colombo A; Zeitschel U; Willem M; Volbracht C; Schepers U; Imhof A; Hoffmeister A; Haass C; Roßner S; Bräse S; Lichtenthaler SF
EMBO J; 2012 Jun; 31(14):3157-68. PubMed ID: 22728825
[TBL] [Abstract][Full Text] [Related]
12. Regulatory role for a conserved motif adjacent to the homeodomain of Hox10 proteins.
Guerreiro I; Casaca A; Nunes A; Monteiro S; Nóvoa A; Ferreira RB; Bom J; Mallo M
Development; 2012 Aug; 139(15):2703-10. PubMed ID: 22721778
[TBL] [Abstract][Full Text] [Related]
13. Gestational exposure to bisphenol a produces transgenerational changes in behaviors and gene expression.
Wolstenholme JT; Edwards M; Shetty SR; Gatewood JD; Taylor JA; Rissman EF; Connelly JJ
Endocrinology; 2012 Aug; 153(8):3828-38. PubMed ID: 22707478
[TBL] [Abstract][Full Text] [Related]
14. The puzzle of TRPV4 channelopathies.
Nilius B; Voets T
EMBO Rep; 2013 Feb; 14(2):152-63. PubMed ID: 23306656
[TBL] [Abstract][Full Text] [Related]
15. TRPV4 channels regulate tumor angiogenesis via modulation of Rho/Rho kinase pathway.
Thoppil RJ; Cappelli HC; Adapala RK; Kanugula AK; Paruchuri S; Thodeti CK
Oncotarget; 2016 May; 7(18):25849-61. PubMed ID: 27029071
[TBL] [Abstract][Full Text] [Related]
16. Structure of the full-length TRPV2 channel by cryo-EM.
Huynh KW; Cohen MR; Jiang J; Samanta A; Lodowski DT; Zhou ZH; Moiseenkova-Bell VY
Nat Commun; 2016 Mar; 7():11130. PubMed ID: 27021073
[TBL] [Abstract][Full Text] [Related]
17. Interaction between the Linker, Pre-S1, and TRP Domains Determines Folding, Assembly, and Trafficking of TRPV Channels.
Garcia-Elias A; Berna-Erro A; Rubio-Moscardo F; Pardo-Pastor C; Mrkonjić S; Sepúlveda RV; Vicente R; González-Nilo F; Valverde MA
Structure; 2015 Aug; 23(8):1404-1413. PubMed ID: 26146187
[TBL] [Abstract][Full Text] [Related]
18. High-resolution views of TRPV1 and their implications for the TRP channel superfamily.
Hellmich UA; Gaudet R
Handb Exp Pharmacol; 2014; 223():991-1004. PubMed ID: 24961977
[TBL] [Abstract][Full Text] [Related]
19. TRPV4: new therapeutic target for inflammatory bowel diseases.
Vergnolle N
Biochem Pharmacol; 2014 May; 89(2):157-61. PubMed ID: 24440740
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol-4,5-biphosphate-dependent rearrangement of TRPV4 cytosolic tails enables channel activation by physiological stimuli.
Garcia-Elias A; Mrkonjic S; Pardo-Pastor C; Inada H; Hellmich UA; Rubio-Moscardó F; Plata C; Gaudet R; Vicente R; Valverde MA
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9553-8. PubMed ID: 23690576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
